Metagenomi Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | — | $190.5M |
| Mar 2023 | — | — | $95.7M |
| Jun 2023 | — | — | $51.6M |
| Sep 2023 | — | — | $101.9M |
| Dec 2023 | $149.7M | $364.8M | $140.6M |
| Mar 2024 | $139.8M | $415.4M | $102.6M |
| Jun 2024 | $116.5M | $385.9M | $61.2M |
| Sep 2024 | $102.6M | $358.3M | $25.1M |
| Dec 2024 | $89.7M | $324.6M | $27.4M |
| Mar 2025 | $85.2M | $297.9M | $29.2M |
| Jun 2025 | $76.5M | $272.3M | $26.9M |
| Sep 2025 | $69.5M | $247.9M | $32.8M |
| Dec 2025 | $62.5M | $221.1M | $41.7M |
| Mar 2026 | $59.2M | $197.0M | $25.3M |
| Jun 2026 | $61.1M | $173.7M | $39.0M |